Supply via a 'specials' or named-patient route is not a routine or straightforward pathway for a new investigational agent of this kind and would require robust regulatory justification
Ozempic, Wegovy, Zepbound, and Mounjaro are dominating the pharmaceutical landscape
Because of the depth, these sores are more painful and take longer to heal
Food & Drug Administration (FDA) expressed safety concerns with compounded GLP-1 drugs
Lixisenatide demonstrated a stronger association with hypoglycemia compared to other GLP-1RAs, according to the highest reporting odds ratio (ROR) (28.03, 95% confidence interval =15.92, 49.32), empirical Bayes geometric mean [26.00, 95% confidence interval (CI): 16.20], and proportional reporting ratio (PRR) (26.01, 2 =313.37)